1-12 of 12
Dolores J. Schendel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 12: TCR-gated control of costimulatory switch protein (CSP) activation in rTCR-T cells expressing PD1-41BB

Free
Maja Buerdek, Petra U. Prinz, Kathrin Mutze, Andrea Coluccio, Stefanie Tippmer, Miriam Bosch, Giulia Longinotti, Mario Catarinella, Kathrin Davari, Christiane Geiger, Barbara Loesch, Kirsty Crame, Dolores J. Schendel
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 12.
https://doi.org/10.1158/1538-7445.AM2024-12
Published: 22 March 2024
View articletitled, Abstract 12: TCR-gated control of costimulatory switch protein (CSP) activation in rTCR-T cells expressing PD1-41BB
Journal Articles

Abstract 4057: T cells co-expressing a highly potent NY-ESO-1-specific TCR and a chimeric PD1-41BB co-stimulatory switch receptor show a favorable polyfunctional profile for the treatment of solid tumors

Free
Andrea Coluccio, Stefanie Tippmer, Petra Prinz, Maja Buerdek, Kathrin Mutze, Barbara Loesch, Kathrin Davari, Giulia Longinotti, Dolores J. Schendel
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4057.
https://doi.org/10.1158/1538-7445.AM2023-4057
Published: 04 April 2023
View articletitled, Abstract 4057: T cells co-expressing a highly potent NY-ESO-1-specific TCR and a chimeric PD1-41BB co-stimulatory switch receptor show a favorable polyfunctional profile for the treatment of solid tumors
Journal Articles

Abstract 3231: The chimeric co-stimulatory receptor PD1-41BB enhances the function of T cell receptor (TCR)-modified T cells targeting solid tumors

Free
Nadja Sailer, Melanie Salvermoser, Maria Gerget, Sarah Thome, Angelika J. Fischbeck, Svenja Ruehland, Luis F. Olguín-Contreras, Maja Buerdek, Christian Ellinger, Elfriede Noessner, Dolores J. Schendel, Patrik Kehler
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3231.
https://doi.org/10.1158/1538-7445.AM2020-3231
Published: 15 August 2020
View articletitled, Abstract 3231: The chimeric co-stimulatory receptor PD1-41BB enhances the function of T cell receptor (TCR)-modified T cells targeting solid tumors
Journal Articles

Abstract 2303: In vitro evaluation of TCR efficacy and toxicity using 3D spheroid models

Free
Maja Buerdek, Kathrin Mutze, Kai Pinkernell, Dolores J. Schendel
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2303.
https://doi.org/10.1158/1538-7445.AM2019-2303
Published: 01 July 2019
View articletitled, Abstract 2303: In vitro evaluation of TCR efficacy and toxicity using 3D spheroid models
Journal Articles

Abstract 5644: Generation of clinical grade autologous TLR 7,8-polarized fast dendritic cell vaccines for active immunotherapy of patients with AML

Free
Iris Bigalke, Lisbeth Johanne Skoge, Kirsti Hønnåshagen, Christiane Geiger, Gunnar Kvalheim, Dolores J. Schendel
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5644.
https://doi.org/10.1158/1538-7445.AM2018-5644
Published: 01 July 2018
View articletitled, Abstract 5644: Generation of clinical grade autologous TLR 7,8-polarized fast dendritic cell vaccines for active immunotherapy of patients with AML
Journal Articles

Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy

Free
Ramona Schlenker, Luis Felipe Olguín-Contreras, Matthias Leisegang, Julia Schnappinger, Anja Disovic, Svenja Rühland, Peter J. Nelson, Heinrich Leonhardt, Hartmann Harz, Susanne Wilde, Dolores J. Schendel, Wolfgang Uckert, Gerald Willimsky, Elfriede Noessner
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (13): 3577–3590.
https://doi.org/10.1158/0008-5472.CAN-16-1922
Published: 02 July 2017
View articletitled, Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
Open the PDF for Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy in another window
Includes: Supplementary data
Journal Articles

Abstract 3659: WT1 and PRAME mRNA transfected TLR 7/8-polarized fast DC vaccines in AML patients mount specific immune responses and impact progression free survival

Free
Iris Bigalke, Guri Solum, Dag Josefsen, Yngvar Fløisand, Kirsti Hønnåshagen, Lisbeth Skoge, Signe Spetalen, Stein Sæbøe-Larssen, Dolores J. Schendel, Gunnar Kvalheim
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3659.
https://doi.org/10.1158/1538-7445.AM2017-3659
Published: 01 July 2017
View articletitled, Abstract 3659: WT1 and PRAME mRNA transfected TLR 7/8-polarized fast DC vaccines in AML patients mount specific immune responses and impact progression free survival
Journal Articles

Abstract 4977: Isolation and characterization of a PRAME-specific TCR with high avidity, potent antitumor efficacy and a favorable preclinical safety profile

Free
Manon Weis, Carina Wehner, Christian Ellinger, Susanne Wilde, Dolores J. Schendel
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4977.
https://doi.org/10.1158/1538-7445.AM2017-4977
Published: 01 July 2017
View articletitled, Abstract 4977: Isolation and characterization of a PRAME-specific TCR with high avidity, potent antitumor efficacy and a favorable preclinical safety profile
Journal Articles

Abstract 2516: A new generation of dendritic cells to improve cancer therapy shows prolonged progression-free survival in patients with solid tumors

Free
Iris Bigalke, Kirsti Honnashagen, Marianne Lundby, Guri Solum, Lisbeth Skoge, Else M. Suso Inderberg, Julitta Kasten, Stein Saboe-Larssen, Dolores J. Schendel, Gunnar Kvalheim
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2516.
https://doi.org/10.1158/1538-7445.AM2015-2516
Published: 01 August 2015
View articletitled, Abstract 2516: A new generation of dendritic cells to improve cancer therapy shows prolonged progression-free survival in patients with solid tumors
Journal Articles

Retaliation against Tumor Cells Showing Aberrant HLA Expression Using Lymphokine Activated Killer-derived T Cells

Free
Christine S. Falk, Elfriede Noessner, Elisabeth H. Weiss, Dolores J. Schendel
Journal: Cancer Research
Cancer Res (2002) 62 (2): 480–487.
Published: 01 January 2002
View articletitled, Retaliation against Tumor Cells Showing Aberrant HLA Expression Using Lymphokine Activated Killer-derived T Cells
Open the PDF for Retaliation against Tumor Cells Showing Aberrant HLA Expression Using Lymphokine Activated Killer-derived T Cells in another window
Journal Articles

Human Renal Cell Carcinoma Antigen-specific CTLs: Antigen-driven Selection and Long-Term Persistence in Vivo

Free
Petra Jantzer, Dolores J. Schendel
Journal: Cancer Research
Cancer Res (1998) 58 (14): 3078–3086.
Published: 01 July 1998
View articletitled, Human Renal Cell Carcinoma Antigen-specific CTLs: Antigen-driven Selection and Long-Term Persistence in Vivo
Open the PDF for Human Renal Cell Carcinoma Antigen-specific CTLs: Antigen-driven Selection and Long-Term Persistence in Vivo in another window
Journal Articles

Tumor-specific Lysis of Human Renal Cell Carcinomas by Tumor-infiltrating Lymphocytes: Modulation of Recognition through Retroviral Transduction of TumorCells with Interleukin 2 Complementary DNA and Exogenous α Interferon Treatment

Free
Dolores J. Schendel, Bernd Gansbacher
Journal: Cancer Research
Cancer Res (1993) 53 (17): 4020–4025.
Published: 01 September 1993
View articletitled, Tumor-specific Lysis of Human Renal Cell Carcinomas by Tumor-infiltrating Lymphocytes: Modulation of Recognition through Retroviral Transduction of TumorCells with Interleukin 2 Complementary DNA and Exogenous α Interferon Treatment
Open the PDF for Tumor-specific Lysis of Human Renal Cell Carcinomas by Tumor-infiltrating Lymphocytes: Modulation of Recognition through Retroviral Transduction of TumorCells with Interleukin 2 Complementary DNA and Exogenous α Interferon Treatment in another window